Seres Therapeutics
MCRB
#10246
Rank
โ‚ฌ2.85 M
Marketcap
0,33ย โ‚ฌ
Share price
1.11%
Change (1 day)
-61.49%
Change (1 year)

Revenue for Seres Therapeutics (MCRB)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of โ‚ฌ0.11 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Seres Therapeutics from 2014 to 2024

Annual revenue

Year Revenue Change
2024 N/A-100%
2023 โ‚ฌ0.11 B1615.45%
2022 โ‚ฌ6.64 M-94.81%
2021 โ‚ฌ0.12 B373.89%
2020 โ‚ฌ27 M-12.33%
2019 โ‚ฌ30.8 M24.66%
2018 โ‚ฌ24.7 M-7.64%
2017 โ‚ฌ26.75 M29.29%
2016 โ‚ฌ20.69 M
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.11 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ98.69 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ30.61 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA